90 related articles for article (PubMed ID: 23825222)
41. MicroRNA-93 elevation after myocardial infarction is cardiac protective.
Li K; Lin T; Chen L; Wang N
Med Hypotheses; 2017 Sep; 106():23-25. PubMed ID: 28818266
[TBL] [Abstract][Full Text] [Related]
42. Myocardial fibrosis induced by exposure to subclinical lipopolysaccharide is associated with decreased miR-29c and enhanced NOX2 expression in mice.
Lew WY; Bayna E; Dalle Molle E; Contu R; Condorelli G; Tang T
PLoS One; 2014; 9(9):e107556. PubMed ID: 25233448
[TBL] [Abstract][Full Text] [Related]
43. MicroRNA-26b relieves inflammatory response and myocardial remodeling of mice with myocardial infarction by suppression of MAPK pathway through binding to PTGS2.
Ge ZW; Zhu XL; Wang BC; Hu JL; Sun JJ; Wang S; Chen XJ; Meng SP; Liu L; Cheng ZY
Int J Cardiol; 2019 Apr; 280():152-159. PubMed ID: 30679074
[TBL] [Abstract][Full Text] [Related]
44. miR-199b-5p is a regulator of left ventricular remodeling following myocardial infarction.
Duygu B; Poels EM; Juni R; Bitsch N; Ottaviani L; Olieslagers S; de Windt LJ; da Costa Martins PA
Noncoding RNA Res; 2017 Mar; 2(1):18-26. PubMed ID: 30159417
[TBL] [Abstract][Full Text] [Related]
45. Down-regulation of miR-133a/b in patients with myocardial infarction correlates with the presence of ventricular fibrillation.
Boštjančič E; Brandner T; Zidar N; Glavač D; Štajer D
Biomed Pharmacother; 2018 Mar; 99():65-71. PubMed ID: 29324314
[TBL] [Abstract][Full Text] [Related]
46. Delivery of lipid micelles into infarcted myocardium using a lipid-linked matrix metalloproteinase targeting peptide.
Nguyen J; Sievers R; Motion JP; Kivimäe S; Fang Q; Lee RJ
Mol Pharm; 2015 Apr; 12(4):1150-7. PubMed ID: 25642730
[TBL] [Abstract][Full Text] [Related]
47. A Soluble Epoxide Hydrolase Inhibitor Upregulated KCNJ12 and KCNIP2 by Downregulating MicroRNA-29 in a Mouse Model of Myocardial Infarction.
Zhang X; Liao C; Sun K; Liu L; Xu D
Heart Surg Forum; 2020 Aug; 23(5):E579-E585. PubMed ID: 32990585
[TBL] [Abstract][Full Text] [Related]
48. Mice with tissue inhibitor of metalloproteinases 4 (Timp4) deletion succumb to induced myocardial infarction but not to cardiac pressure overload.
Koskivirta I; Kassiri Z; Rahkonen O; Kiviranta R; Oudit GY; McKee TD; Kytö V; Saraste A; Jokinen E; Liu PP; Vuorio E; Khokha R
J Biol Chem; 2010 Aug; 285(32):24487-93. PubMed ID: 20516072
[TBL] [Abstract][Full Text] [Related]
49. Analysis of coding sequences for tissue inhibitor of metalloproteinases 1 (TIMP1) and 2 (TIMP2) in patients with aneurysms.
Wang X; Tromp G; Cole CW; Verloes A; Sakalihasan N; Yoon S; Kuivaniemi H
Matrix Biol; 1999 Apr; 18(2):121-4. PubMed ID: 10372551
[TBL] [Abstract][Full Text] [Related]
50. Tissue Inhibitor of Metalloproteinase 1 Influences Vascular Adaptations to Chronic Alterations in Blood Flow.
Mandel ER; Uchida C; Nwadozi E; Makki A; Haas TL
J Cell Physiol; 2017 Apr; 232(4):831-841. PubMed ID: 27430487
[TBL] [Abstract][Full Text] [Related]
51. MicroRNAs, innate immunity and ventricular rupture in human myocardial infarction.
Zidar N; Boštjančič E; Glavač D; Stajer D
Dis Markers; 2011; 31(5):259-65. PubMed ID: 22048267
[TBL] [Abstract][Full Text] [Related]
52. MicroRNA miR-1 is up-regulated in remote myocardium in patients with myocardial infarction.
Bostjancic E; Zidar N; Stajner D; Glavac D
Folia Biol (Praha); 2010; 56(1):27-31. PubMed ID: 20163779
[TBL] [Abstract][Full Text] [Related]
53. Therapeutic potential of miR-21 regulation by human peripheral blood derived-small extracellular vesicles in myocardial infarction.
Kang JY; Kim H; Mun D; Yun N; Joung B
Clin Sci (Lond); 2020 Apr; 134(8):985-999. PubMed ID: 32297634
[TBL] [Abstract][Full Text] [Related]
54. MicroRNA 214 Is a Potential Regulator of Thyroid Hormone Levels in the Mouse Heart Following Myocardial Infarction, by Targeting the Thyroid-Hormone-Inactivating Enzyme Deiodinase Type III.
Janssen R; Zuidwijk MJ; Muller A; van Mil A; Dirkx E; Oudejans CB; Paulus WJ; Simonides WS
Front Endocrinol (Lausanne); 2016; 7():22. PubMed ID: 27014189
[TBL] [Abstract][Full Text] [Related]
55. Increased local delivery of antagomir therapeutics to the rodent myocardium using ultrasound and microbubbles.
Kwekkeboom RF; Sluijter JP; van Middelaar BJ; Metz CH; Brans MA; Kamp O; Paulus WJ; Musters RJ
J Control Release; 2016 Jan; 222():18-31. PubMed ID: 26616760
[TBL] [Abstract][Full Text] [Related]
56. Cardiosome mediated regulation of MMP9 in diabetic heart: role of mir29b and mir455 in exercise.
Chaturvedi P; Kalani A; Medina I; Familtseva A; Tyagi SC
J Cell Mol Med; 2015 Sep; 19(9):2153-61. PubMed ID: 25824442
[TBL] [Abstract][Full Text] [Related]
57. Comparative analysis of gene expression in human blood cells and in rhabdomyosarcoma cells pretreated with antimutagens.
Zasukhina GD; Shishkina AA; Vasilyeva IM; Rogozhin EA; Mikhajlov VF; Raeva NF; Shulenina LV; Gromov SP; Alfimov MV
Dokl Biochem Biophys; 2014; 457():160-2. PubMed ID: 25172342
[No Abstract] [Full Text] [Related]
58. miR-21 is a critical therapeutic target for renal fibrosis.
He Y; Huang C; Li J
Cell Biochem Biophys; 2014 Apr; 68(3):635-6. PubMed ID: 24126704
[No Abstract] [Full Text] [Related]
59. Genetic variants of tissue inhibitors of matrix metalloproteinase 1 (rs4898) and 2 (rs8179090) in diverticulosis.
Nehring P; Gromadzka G; Giermaziak A; Jastrzębski M; Przybyłkowski A
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e431-e434. PubMed ID: 33731593
[TBL] [Abstract][Full Text] [Related]
60. Small molecular inhibitors of miR-1 identified from photocycloadducts of acetylenes with 2-methoxy-1,4-naphthalenequinone.
Tan SB; Huang C; Chen X; Wu Y; Zhou M; Zhang C; Zhang Y
Bioorg Med Chem; 2013 Oct; 21(20):6124-31. PubMed ID: 23685176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
